104 related articles for article (PubMed ID: 22123712)
1. Alteration in lipid and protein profiles of ovarian cancer: similarity to breast cancer.
Kang S; Lee A; Park YS; Lee SC; Park SY; Han SY; Kim KP; Kim YH; Yoo CW; Kim HK
Int J Gynecol Cancer; 2011 Dec; 21(9):1566-72. PubMed ID: 22123712
[TBL] [Abstract][Full Text] [Related]
2. Lipid MALDI profile classifies non-small cell lung cancers according to the histologic type.
Lee GK; Lee HS; Park YS; Lee JH; Lee SC; Lee JH; Lee SJ; Shanta SR; Park HM; Kim HR; Kim IH; Kim YH; Zo JI; Kim KP; Kim HK
Lung Cancer; 2012 May; 76(2):197-203. PubMed ID: 22099218
[TBL] [Abstract][Full Text] [Related]
3. Protein and lipid MALDI profiles classify breast cancers according to the intrinsic subtype.
Kang HS; Lee SC; Park YS; Jeon YE; Lee JH; Jung SY; Park IH; Jang SH; Park HM; Yoo CW; Park SH; Han SY; Kim KP; Kim YH; Ro J; Kim HK
BMC Cancer; 2011 Oct; 11():465. PubMed ID: 22029885
[TBL] [Abstract][Full Text] [Related]
4. Lipid profiles for intrahepatic cholangiocarcinoma identified using matrix-assisted laser desorption/ionization mass spectrometry.
Park YS; Yoo CW; Lee SC; Park SJ; Oh JH; Yoo BC; Paik SS; Lee KG; Jin SY; Kim SC; Kim KP; Kim YH; Choi D; Kim HK
Clin Chim Acta; 2011 Oct; 412(21-22):1978-82. PubMed ID: 21777572
[TBL] [Abstract][Full Text] [Related]
5. Lipid profiles for HER2-positive breast cancer.
Kim IC; Lee JH; Bang G; Choi SH; Kim YH; Kim KP; Kim HK; Ro J
Anticancer Res; 2013 Jun; 33(6):2467-72. PubMed ID: 23749897
[TBL] [Abstract][Full Text] [Related]
6. Matrix-assisted laser desorption/ionization mass spectrometry reveals decreased calcylcin expression in small cell lung cancer.
Lee HS; Park JW; Chertov O; Colantonio S; Simpson JT; Fivash MJ; Yoo CW; Lee GK; Zo JI; Kim HT; Kim HK
Pathol Int; 2012 Jan; 62(1):28-35. PubMed ID: 22192801
[TBL] [Abstract][Full Text] [Related]
7. Histology-directed matrix-assisted laser desorption/ionization analysis reveals tissue origin and p53 status of primary liver cancers.
Jeon YE; Lee SC; Paik SS; Lee KG; Jin SY; Kim HR; Yoo CW; Park HM; Han SY; Choi DH; Kim HK
Pathol Int; 2011 Aug; 61(8):449-55. PubMed ID: 21790858
[TBL] [Abstract][Full Text] [Related]
8. Mass spectrometric profiling reveals association of N-glycan patterns with epithelial ovarian cancer progression.
Chen H; Deng Z; Huang C; Wu H; Zhao X; Li Y
Tumour Biol; 2017 Jul; 39(7):1010428317716249. PubMed ID: 28681696
[TBL] [Abstract][Full Text] [Related]
9. Comparative proteomics of ovarian epithelial tumors.
An HJ; Kim DS; Park YK; Kim SK; Choi YP; Kang S; Ding B; Cho NH
J Proteome Res; 2006 May; 5(5):1082-90. PubMed ID: 16674097
[TBL] [Abstract][Full Text] [Related]
10. The comparison of glycosphingolipids isolated from an epithelial ovarian cancer cell line and a nontumorigenic epithelial ovarian cell line using MALDI-MS and MALDI-MS/MS.
Rajanayake KK; Taylor WR; Isailovic D
Carbohydr Res; 2016 Aug; 431():6-14. PubMed ID: 27267063
[TBL] [Abstract][Full Text] [Related]
11. Fine Needle Aspiration Combined With Matrix-assisted Laser Desorption Ionization Time-of-Flight/Mass Spectrometry to Characterize Lipid Biomarkers for Diagnosing Accuracy of Breast Cancer.
Cho YT; Su H; Chiang YY; Shiea J; Yuan SF; Hung WC; Yeh YT; Hou MF
Clin Breast Cancer; 2017 Aug; 17(5):373-381.e1. PubMed ID: 28648841
[TBL] [Abstract][Full Text] [Related]
12. Protein expression changes in ovarian cancer during the transition from benign to malignant.
Waldemarson S; Krogh M; Alaiya A; Kirik U; Schedvins K; Auer G; Hansson KM; Ossola R; Aebersold R; Lee H; Malmström J; James P
J Proteome Res; 2012 May; 11(5):2876-89. PubMed ID: 22471520
[TBL] [Abstract][Full Text] [Related]
13. Proteomic analysis reflects different histologic subtypes of epithelial ovarian cancer.
Jia L; Zhang H; Qu X; Deng B; Kong B
Med Hypotheses; 2012 Mar; 78(3):407-9. PubMed ID: 22227042
[TBL] [Abstract][Full Text] [Related]
14. Depletion of Dicer promotes epithelial ovarian cancer progression by elevating PDIA3 expression.
Zhu Y; Cai L; Guo J; Chen N; Yi X; Zhao Y; Cai J; Wang Z
Tumour Biol; 2016 Oct; 37(10):14009-14023. PubMed ID: 27492604
[TBL] [Abstract][Full Text] [Related]
15. The use of laser microdissection and SELDI-TOF MS in ovarian cancer tissue to identify protein profiles.
Cadron I; Van Gorp T; Amant F; Vergote I; Moerman P; Waelkens E; Daemen A; Van De Plas R; De Moor B; Zeillinger R
Anticancer Res; 2009 Apr; 29(4):1039-45. PubMed ID: 19414343
[TBL] [Abstract][Full Text] [Related]
16. Molecular diagnosis in type I epithelial ovarian cancer.
Sadłecki P; Walentowicz-Sadłecka M; Grabiec M
Ginekol Pol; 2017; 88(12):692-697. PubMed ID: 29303228
[TBL] [Abstract][Full Text] [Related]
17. Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urine.
Ye B; Skates S; Mok SC; Horick NK; Rosenberg HF; Vitonis A; Edwards D; Sluss P; Han WK; Berkowitz RS; Cramer DW
Clin Cancer Res; 2006 Jan; 12(2):432-41. PubMed ID: 16428483
[TBL] [Abstract][Full Text] [Related]
18. Targeted Feature Extraction in MALDI Mass Spectrometry Imaging to Discriminate Proteomic Profiles of Breast and Ovarian Cancer.
Cordero Hernandez Y; Boskamp T; Casadonte R; Hauberg-Lotte L; Oetjen J; Lachmund D; Peter A; Trede D; Kriegsmann K; Kriegsmann M; Kriegsmann J; Maass P
Proteomics Clin Appl; 2019 Jan; 13(1):e1700168. PubMed ID: 30520240
[TBL] [Abstract][Full Text] [Related]
19. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
[No Abstract] [Full Text] [Related]
20. Surface analysis of lipids by mass spectrometry: more than just imaging.
Ellis SR; Brown SH; In Het Panhuis M; Blanksby SJ; Mitchell TW
Prog Lipid Res; 2013 Oct; 52(4):329-53. PubMed ID: 23623802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
